|
FY2025
12 months to Oct 4, 2025
|
FY2024
12 months to Sep 28, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Oct 1, 2022
|
FY2021
12 months to Oct 2, 2021
|
|
|---|---|---|---|---|---|
| Net revenue | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Gain relating to cessation of business | |||||
| Impairment charges | |||||
| Operating expenses | |||||
| (Loss) / Income from operations | |||||
| Interest income | |||||
| Interest expense | |||||
| Income / (Loss) before income taxes | |||||
| Provision for income taxes | |||||
| Share of results of equity-method investee, net of tax | |||||
| Net income / (loss) | |||||
| Net income / (loss) per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...
